Research article summary:

Influence of the severity of cognitive impairment on the effect of the Gnkgo biloba extract EGb 761 in Alzheimers disease.

Abstract Extract:
OBJECTIVE: To explore the treatment effect of EGb 761((R)) (EGb) in Alzheimers disease depending on baseline severity. METHODS: We applied stratification to the intent-to-treat data set collected during a 52-week, randomized, double-blind, ... (Full abstract text below)

Published 2002 in Journal: Neuropsychobiology (Language : eng)

Full Pubmed Extract

This information was retrieved, real-time, on your behalf from the public area of the Pubmed website:

1. Neuropsychobiology. 2002 ;45(1):19-26

Influence of the severity of cognitive impairment on the effect of the Gnkgo biloba extract EGb 761 in Alzheimer's disease.

Le Bars PL, Velasco FM, Ferguson JM, Dessain EC, Kieser M, Hoerr R

New York University Medical Center and Memory Centers of America, New York, NY, USA.

OBJECTIVE: To explore the treatment effect of EGb 761((R)) (EGb) in Alzheimer's disease depending on baseline severity. METHODS: We applied stratification to the intent-to-treat data set collected during a 52-week, randomized, double-blind, placebo-controlled, parallel-group, multicenter study with 120 mg of EGb, using cutoff points of 23 and 14 for the Mini-Mental State Examination (MMSE) score. Outcome measures used were the cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog) and the Geriatric Evaluation by Relative's Rating Instrument (GERRI). RESULTS: In the severity stratum 1 (MMSE >23), the placebo group did not show significant changes, while the EGb group improved significantly by 1.7 points on the ADAS-Cog and by 0.09 points on the GERRI. In the severity stratum 2 (MMSE <24), the placebo group worsened by 4.1 points on the ADAS-Cog and 0.18 points on the GERRI, whereas the EGb group showed 60% less decline on the ADAS-Cog (treatment difference of 2.5 points) and no change on the GERRI (treatment difference of 0.25 points). The most severely impaired subgroup (MMSE <15) showed slightly more pronounced worsening for both treatment groups. However, in comparison to placebo, EGb induced virtually the same magnitude of effect as was observed in the entire stratum 2. CONCLUSIONS: The results of this retrospective analysis indicated that a treatment effect favorable to EGb could be observed with respect to cognitive performance (p = 0.02) and social functioning (p = 0.001) regardless of the stage of dementia, whether mild or moderately severe. However, the relative changes from baseline measured at endpoint depended heavily on the severity at baseline. Improvement was observed in the group of patients with very mild to mild cognitive impairment, while in more severe dementia, the mean EGb effect should be considered more in terms of stabilization or slowing down of worsening, as compared to the greater deterioration observed with placebo.

PMID : 11803237 [PubMed - Indexed for MEDLINE]

This information is obtained from the National Library of Medicine (NLM). Abstract text and other information may be subject to copyright. Type "NLM copyright" into Google for more information.

Full Author Information

First Name	LastName	Initials
P L	Le Bars	PL
F M	Velasco	FM
J M	Ferguson	JM
E C	Dessain	EC
M	Kieser	M
R	Hoerr	R

Affiliation: New York University Medical Center and Memory Centers of America, New York, NY, USA.

3rd Party provider links

Click the links below to go to related 3rd party information:

MESH categories and related page links

This article was linked to the MESH categories shown on the left below. The links on the right are related Memletics pages.

Links for this article

For links to places where you can get the full text of this article see links. Note there may be a subscription or fee required for access to the full text.

New! Using similar technology to this site, we have launched find-health-articles.com, targeting over 1 million health research article abstracts.

Here are some articles related to this one (by title keywords):

Effect of age of onset of temporal lobe epilepsy on the severity and the nature of preoperative memory deficits.

Severity of intimate partner abuse indicators as perceived by women in Mexico and the United States.

Pharmacoeconomics of mild cognitive impairment.

Music listening for maintaining attention of older adults with cognitive impairments.

Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

Sertraline treatment of elderly patients with depression and cognitive impairment.

Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease.

Modeling the prevalence and incidence of Alzheimers disease and mild cognitive impairment.

The Mental Health Act 1983 section 5(2): clinical application and predictors of outcome.

Life expectancy with cognitive impairment in the older population of the United States.

>>> Get more research article abstracts like these, or browse abstracts.

Keywords in this article:

adas, alzheimer, analysis, applied, assessment, baseline, blind, changes, cognitive, collected, compared, comparison, conclusions, considered, controlled, cutoff, data, decline, dementia, depended, depending, deterioration, difference, disease, double, down, effect, egb, endpoint, entire, evaluation, examination, explore, favorable, functioning, geriatric, gerri, greater, group, groups, heavily, impaired, impairment, improved, improvement, indicated, induced, instrument, intent, less, magnitude, mean, measured, measures, mental, methods, mild, mini, mmse, moderately, more, multicenter, not, objective, observed, outcome, parallel, patients, performance, placebo, points, pronounced, randomized, rating, regardless, relative, respect, results, retrospective, s, same, score, set, severely, severity, significant, slightly, slowing, social, stabilization, stage, state, stratification, stratum, study, subgroup, subscale, terms, treatment, virtually, week, whereas, whether, worsened, worsening

Also, see our new free speed reading online course (beta version)